Cargando…
707. QPX9003: Pharmacology of a Novel Polymyxin in Mice and Rats
BACKGROUND: Currently available polymyxins are limited by toxicity and poor efficacy at tolerated doses. We have developed a new series of polymyxin derivatives with improved safety profiles and in vitro potency against major MDR bacteria. The following describes studies on the in vivo antimicrobial...
Autores principales: | Sabet, Mojgan, Tarazi, Ziad, Parkinson, Jonathan, Roberts, Kade, Thompson, Philip, Nation, Roger, Velkov, Tony, Hecker, Scott, Lomovskaya, Olga, Dudley, Michael, Li, Jian, Grifith, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811056/ http://dx.doi.org/10.1093/ofid/ofz360.775 |
Ejemplares similares
-
690. Activity of a Novel Polymyxin Analog, QPX9003, Tested Against Resistant Gram-Negative Pathogens, Including Carbapenem-Resistant Acinetobacter, Enterobacterales, and Pseudomonas
por: Castanheira, Mariana, et al.
Publicado: (2019) -
Design and Evaluation of Novel Polymyxin Fluorescent Probes
por: Yun, Bo, et al.
Publicado: (2017) -
Teaching ‘Old’ Polymyxins New Tricks:
New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
por: Velkov, Tony, et al.
Publicado: (2014) -
Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus
por: Zhao, Jinxin, et al.
Publicado: (2016) -
QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics
por: Lomovskaya, Olga, et al.
Publicado: (2021)